NCT06189027View on ClinicalTrials.gov

Epigenetics and MDMA-Assisted Psychotherapy for PTSD

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 20, 2018

Primary Completion Date

November 1, 2023

Study Completion Date

December 31, 2024

Conditions
PTSD
Interventions
DRUG

MDMA

Adjunctive administration of MDMA to assist psychotherapeutic process

BEHAVIORAL

Psychotherapy

Psychotherapy aimed at assisting with PTSD symptom reduction

Trial Locations (1)

90089

Univeristy of Southern California, Los Angeles

All Listed Sponsors
collaborator

Multidisciplinary Association for Psychedelic Studies

OTHER

lead

University of Southern California

OTHER